Marie Kostine

5.4k total citations · 2 hit papers
48 papers, 2.4k citations indexed

About

Marie Kostine is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marie Kostine has authored 48 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Oncology, 10 papers in Pathology and Forensic Medicine and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marie Kostine's work include Cancer Immunotherapy and Biomarkers (21 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Marie Kostine is often cited by papers focused on Cancer Immunotherapy and Biomarkers (21 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Marie Kostine collaborates with scholars based in France, Netherlands and Switzerland. Marie Kostine's co-authors include Thierry Schaeverbeke, Marie‐Elise Truchetet, Thomas Barnetche, B Bannwarth, A Bertrand, Judith V.M.G. Bovée, Alexander R. Lyon, Caroline Robert, John B.A.G. Haanen and Michel Obéid and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and Annals of the Rheumatic Diseases.

In The Last Decade

Marie Kostine

45 papers receiving 2.3k citations

Hit Papers

Management of toxicities from ... 2015 2026 2018 2022 2022 2015 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
    2022 565 citations Marie Kostine et al. profile →
  2. Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
    2015 540 citations Marie Kostine, Thomas Barnetche et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie Kostine France 21 1.5k 549 527 286 285 48 2.4k
Luís Teixeira France 28 1.1k 0.7× 698 1.3× 585 1.1× 604 2.1× 255 0.9× 93 3.3k
Attilio Olivieri Italy 33 1.1k 0.7× 260 0.5× 801 1.5× 568 2.0× 111 0.4× 156 3.6k
Inês Pires da Silva Australia 25 1.0k 0.7× 247 0.4× 808 1.5× 539 1.9× 107 0.4× 106 2.0k
Nadège Corradini France 27 738 0.5× 994 1.8× 185 0.4× 552 1.9× 431 1.5× 134 2.3k
Anna M. Dahlin Sweden 15 917 0.6× 457 0.8× 383 0.7× 494 1.7× 85 0.3× 36 1.8k
Maya Koren‐Michowitz Israel 22 791 0.5× 236 0.4× 593 1.1× 859 3.0× 124 0.4× 76 2.9k
Karen Dresser United States 29 616 0.4× 605 1.1× 428 0.8× 1.0k 3.5× 325 1.1× 75 2.7k
Ofer Merimsky Israel 30 1.2k 0.8× 1.3k 2.4× 256 0.5× 482 1.7× 402 1.4× 188 2.9k
Su‐Jin Shin South Korea 23 947 0.6× 852 1.6× 265 0.5× 461 1.6× 106 0.4× 153 2.2k

Countries citing papers authored by Marie Kostine

Since Specialization
Citations

This map shows the geographic impact of Marie Kostine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Kostine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Kostine more than expected).

Fields of papers citing papers by Marie Kostine

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Kostine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Kostine. The network helps show where Marie Kostine may publish in the future.

Co-authorship network of co-authors of Marie Kostine

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Kostine. A scholar is included among the top collaborators of Marie Kostine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Kostine. Marie Kostine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roubaud, Guilhem, Marie Kostine, Ray McDermott, et al.. (2025). Assessment of bone mineral density in men with de novo metastatic castration-sensitive prostate cancer treated with or without abiraterone acetate plus prednisone in the PEACE-1 phase 3 trial. European Journal of Cancer. 218. 115293–115293. 2 indexed citations
2.
3.
Barnetche, Thomas, S. Prey, Caroline Dutriaux, et al.. (2024). Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational study. Joint Bone Spine. 92(1). 105795–105795. 1 indexed citations
4.
Ghosh, Nilasha, Bridget Jivanelli, Namrata Singh, et al.. (2024). The Need for Classification Criteria of Immune Checkpoint Inhibitor-induced inflammatory Arthritis. Rheumatic Disease Clinics of North America. 50(2). 325–335. 2 indexed citations
5.
6.
Prey, S., Caroline Dutriaux, E. Gérard, et al.. (2023). Clinical impact of proton pump inhibitors and other co-medications on advanced melanoma patients treated with BRAF/MEK inhibitors. European Journal of Cancer. 197. 113477–113477. 3 indexed citations
7.
Barnetche, Thomas, Julien Sénéschal, Élodie Blanchard, et al.. (2023). Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study. Joint Bone Spine. 90(3). 105555–105555. 7 indexed citations
8.
Tison, Alice, Soizic Garaud, Laurent Chiche, Divi Cornec, & Marie Kostine. (2022). Immune-checkpoint inhibitor use in patients with cancer and pre-existing autoimmune diseases. Nature Reviews Rheumatology. 18(11). 641–656. 98 indexed citations
9.
Lam, Suk Wai, Marie Kostine, Noel F.C.C. de Miranda, et al.. (2021). Mismatch repair deficiency is rare in bone and soft tissue tumors. Histopathology. 79(4). 509–520. 29 indexed citations
10.
Dousset, L., Thomas Barnetche, Marie Kostine, et al.. (2021). Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti–programmed cell death-1 therapies for melanoma: A cross-sectional study. JAAD International. 5. 112–120. 15 indexed citations
11.
Piperno, Muriel, Marie Kostine, Denis Maillet, et al.. (2021). Effets secondaires rhumatologiques immuno-induits par les inhibiteurs de points de contrôle de la réponse immunitaire. Bulletin du Cancer. 108(6). 643–653. 2 indexed citations
12.
Najm, Aurélie, Marie Kostine, John D Pauling, et al.. (2020). Multidisciplinary collaboration among young specialists: results of an international survey by the emerging EULAR network and other young organisations. RMD Open. 6(2). e001398–e001398. 6 indexed citations
13.
14.
Kostine, Marie, Aurélien Marabelle, Thierry Schaeverbeke, & Maria Kfoury. (2019). Les limites des inhibiteurs de points de contrôle immunitaire et la gestion de leur toxicité. médecine/sciences. 35(12). 949–956. 2 indexed citations
15.
Prével, Renaud, et al.. (2018). Dark urine, hypotension and blood smear examination. Intensive Care Medicine. 45(7). 1015–1016. 1 indexed citations
16.
Kostine, Marie, L. Rouxel, Thomas Barnetche, et al.. (2017). Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study. Annals of the Rheumatic Diseases. 77(3). 393–398. 208 indexed citations
17.
Kostine, Marie, et al.. (2017). Immune checkpoint inhibitors in sarcomas: in quest of predictive biomarkers. Laboratory Investigation. 98(1). 41–50. 28 indexed citations
18.
Kostine, Marie, Arjen H.G. Cleven, Noel F.C.C. de Miranda, et al.. (2016). Analysis of PD-L1, T-cell infiltrate and HLA expression in chondrosarcoma indicates potential for response to immunotherapy specifically in the dedifferentiated subtype. Modern Pathology. 29(9). 1028–1037. 86 indexed citations
19.
Schaeverbeke, Thierry, Marie‐Elise Truchetet, Marie Kostine, et al.. (2015). Immunogenicity of biologic agents in rheumatoid arthritis patients: lessons for clinical practice. Lara D. Veeken. 55(2). 210–220. 77 indexed citations
20.
Bannwarth, B, et al.. (2011). Nonspecific low back pain: Assessment of available medications. Joint Bone Spine. 79(2). 134–136. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luís Teixeira Breakdown of academic impact, for papers by Attilio Olivieri Breakdown of academic impact, for papers by Inês Pires da Silva Breakdown of academic impact, for papers by Nadège Corradini Breakdown of academic impact, for papers by Anna M. Dahlin Breakdown of academic impact, for papers by Maya Koren‐Michowitz Breakdown of academic impact, for papers by Karen Dresser Breakdown of academic impact, for papers by Ofer Merimsky Breakdown of academic impact, for papers by Su‐Jin Shin
Rankless by CCL
2026